RecruitingNCT02568878
Creatine for depression and methamphetamine use
About this title
Read the official source — NCT02568878Medication studyAges 18–59United States
Understand this study
Who could participate?
Listed age limits: 18 years to 59 years.
- Listed locations
- MissoulaSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNovember 2015
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 29
- Sponsor
- Montana State University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 18 Years to 59 Years
- Official registry ID
- NCT02568878
- Official title
Show the full official title
An Open-Label Pilot Study of Creatine for Depressed Male and Female Methamphetamine Users
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Missoula
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Montana State University, a university.
Does this study involve medication?
Yes. The study involves medication, including Creatine monohydrate.
Who can participate?
Listed age limits: 18 years to 59 years.
Is this study still recruiting?
The registry lists this study as recruiting.
